Last reviewed · How we verify
rPA102 Vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
rPA102 Vaccine (rPA102 Vaccine) — VaxGen.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| rPA102 Vaccine TARGET | rPA102 Vaccine | VaxGen | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- rPA102 Vaccine CI watch — RSS
- rPA102 Vaccine CI watch — Atom
- rPA102 Vaccine CI watch — JSON
- rPA102 Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). rPA102 Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/rpa102-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab